Møller, Søren, et al. “A Phase II Trial With Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy”. Acta Oncologica, vol. 51, no. 6, July 2012, pp. 797-04, doi:10.3109/0284186X.2012.681063.